Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE) [Phase 4]

View source ↗

Summary

A Phase 4 trial named THRomboprophylaxis in Individuals Undergoing Superficial Endovenous Treatment (THRIVE) is currently recruiting, sponsored by Imperial Coll…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Imperial College London | Conditions: Venous Thromboembolism, Varicose Veins | Phase 4 | Status: RECRUITING